表紙
市場調査レポート

MediPoint:女性医療 - 世界市場の分析と予測

MediPoint: Women's Health - Global Analysis and Market Forecasts

発行 GlobalData 商品コード 349765
出版日 ページ情報 英文 350 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
MediPoint:女性医療 - 世界市場の分析と予測 MediPoint: Women's Health - Global Analysis and Market Forecasts
出版日: 2015年11月01日 ページ情報: 英文 350 Pages
概要

女性医療の関連技術には、子宮内膜装置、子宮内膜切除装置、子宮筋腫塞栓物質、女性用避妊具、女性用尿失禁スリングなどが含まれます。

当レポートでは、世界の女性医療市場について調査分析し、主要10ヶ国 (米国、フランス、ドイツ、イタリア、スペイン、英国、日本、中国、インド、ブラジル) の競合情勢、上市・パイプライン製品、現在・新興の企業、セグメント別の市場分析など、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

第3章 産業の概要

  • 概要
  • 適応
  • 臨床所見
  • 市場区分
  • 市場参入
  • 臨床試験の影響
  • 採用
  • 規制
  • 償還
  • 処置の動向
  • 規制問題/リコール
  • M&A、主な提携
  • 経済的影響

第4章 アンメットニーズ

  • 概要
  • 子宮内膜アブレーション/切除装置
  • 子宮筋腫塞栓物質
  • 女性用避妊具
  • 女性用尿失禁スリング

第5章 市場機会分析

  • 概要
  • 子宮内膜アブレーション/切除装置
  • 子宮筋腫塞栓物質
  • 女性用避妊具
  • 女性用尿失禁スリング

第6章 市場促進要因と障壁

  • 子宮内膜アブレーション/切除装置
  • 子宮筋腫塞栓物質
  • 女性用避妊具
  • 女性用尿失禁スリング

第7章 競合評価

  • 概要
  • 機能別の分類
  • 主要製品プロファイル

第8章 パイプライン評価

  • 概要
  • 主要製品プロファイル

第9章 注目すべき臨床試験

第10章 現在・将来の主要企業

  • 概要
  • 企業戦略の動向
  • 企業プロファイル
    • American Medical Systems
    • AngioDynamics
    • Bayer Healthcare (Bayer AG)
    • Boston Scientific
    • BTG
    • Coloplast
    • Cook Medical
    • CooperSurgical
    • C.R. Bard
    • Ethicon (Johnson & Johnson)
    • Femcare-Nikomed (Utah Medical Products)
    • Hologic
    • Karl Storz
    • オリンパス
    • Richard Wolf
    • Stryker

第11章 市場見通し

  • 企業の市場シェア
  • 市場セグメント別
  • 地域別

第12章 付録

図表

目次
Product Code: GDME0218MAR

The women's health medical devices market encompasses treatments for conditions that are particular to the adult female anatomy. This includes abnormal uterine conditions, such as menorrhagia and uterine fibroids, as well as pelvic disorders such as female stress urinary incontinence. Moreover, there is a sub-segment of the female population that no longer desire to become pregnant, and seek permanent solutions to avoid conception.

In recent years, minimally invasive techniques and technologies have been developed to treat these conditions as alternatives to conventional surgery; these technologies are expected to see increased adoption in the coming years due to increased physician and patient awareness as well as an increasing number of women who are proactively seeking treatment for these embarrassing, and sometimes debilitating, conditions. However, recent lawsuits related to safety issues with some of these devices that are receiving widespread media attention, particularly in the urinary incontinence sling market, have caused some women to be skeptical of these newer technologies.

The technologies covered in this report include global endometrial devices, endometrial resection devices, uterine fibroid embolization agents, female sterilization devices, and female urinary incontinence slings. This report focuses on the global women's health market in the 10 major markets (10MM) (US, France, Germany, Italy, Spain, UK, Japan, China, India, and Brazil). This report provides insight into the competitive landscape, the marketed and pipeline products, the current and emerging players, and market analysis of each segment. The report identifies the unmet needs in the market while providing an understanding of physicians' perceptions and decision-making processes in using and evaluating the adoption of different types of women's health devices.

Highlights

Key Questions Answered

  • What is the current and future women's health market outlook in the developed and emerging markets? What trends are affecting the global market?
  • Which are the key, high growth markets that manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
  • What are the unmet needs with women's health devices currently on the market? How will emerging technologies fulfill these unmet needs?
  • What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for women's health devices?
  • What are the challenges that have hindered widespread adoption of newer technologies?
  • With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global women's health market?

Scope

  • Overview of women's health, including anatomy, epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.
  • Annualized total women's health market revenue by type of device, direct and indirect costs of disease, procedure trends, and market outlooks by country through 2021.
  • Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies on the market.
  • Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.
  • Analysis of the current and future market competition in the global women's health market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

  • "What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading gynecologists, urogynecologists, interventional radiologists, and general surgeons from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Overview
    • 3.1.1. Anatomy
  • 3.2. Indications
    • 3.2.1. Overview
    • 3.2.2. Abnormal Uterine Conditions
    • 3.2.3. Female Urinary Incontinence
  • 3.3. Clinical Presentation
    • 3.3.1. Abnormal Uterine Conditions
    • 3.3.2. Female Urinary Incontinence
  • 3.4. Market Segmentation
  • 3.5. Market Access
    • 3.5.1. Purchasing Decisions
  • 3.6. Influence of Clinical Trials
  • 3.7. Adoption
  • 3.8. Regulation
    • 3.8.1. US
    • 3.8.2. 5EU
    • 3.8.3. Asia-Pacific
    • 3.8.4. South America
  • 3.9. Reimbursement
    • 3.9.1. US
    • 3.9.2. 5EU
    • 3.9.3. Asia-Pacific
    • 3.9.4. South America
  • 3.10. Procedure Trends
    • 3.10.1. Global Overview
    • 3.10.2. By Region
  • 3.11. Regulatory Issues/Recalls
    • 3.11.1. Hologic Discontinues Manufacturing, Marketing, and Sales of Adiana
    • 3.11.2. Recall of Numerous Transvaginal Mesh Products
  • 3.12. M&As, Key Partnerships
    • 3.12.1. Bayer Health Acquires Conceptus for $1.1 Billion
    • 3.12.2. Boston Scientific Acquires IoGyn for $65m
  • 3.13. Economic Impact
    • 3.13.1. Indirect Costs
    • 3.13.2. Direct Costs

4. Unmet Needs

  • 4.1. Overview
  • 4.2. Endometrial Ablation/Resection Devices
    • 4.2.1. Better Fluid Management
    • 4.2.2. Improved Imaging Guidance
    • 4.2.3. Regulating Depth of Ablation
  • 4.3. Uterine Fibroid Embolization Agents
    • 4.3.1. Addressing Fibroid Recurrence
    • 4.3.2. Assessing Effect on Fertility
    • 4.3.3. Preventing Ovarian Failure
  • 4.4. Female Sterilization Devices
    • 4.4.1. Accelerated Scar Tissue Formation
    • 4.4.2. Lack of Reversibility
    • 4.4.3. Preventing Micro-insert Migration
    • 4.4.4. Preventing Perforation
    • 4.4.5. Trocar Size Reduction
  • 4.5. Female Urinary Incontinence Slings
    • 4.5.1. Anatomical Adaptation
    • 4.5.2. Single-Incision Slings

5. Market Opportunity Analysis

  • 5.1. Overview
  • 5.2. Endometrial Ablation/Resection Devices
    • 5.2.1. Targeted Fibroid Ablation
  • 5.3. Uterine Fibroid Embolization Agents
    • 5.3.1. Novel Agents
  • 5.4. Female Sterilization Devices
    • 5.4.1. Raising Patient Awareness
    • 5.4.2. Rapid Transcervical Sterilization
  • 5.5. Female Urinary Incontinence Slings
    • 5.5.1. Materials and Coatings
    • 5.5.2. European and APAC Markets

6. Market Drivers and Barriers

  • 6.1. Endometrial Ablation/Resection
    • 6.1.1. Driver: Patient Preference for Minimally Invasive Treatments
    • 6.1.2. Driver: Growing Procedure Volume
    • 6.1.3. Barrier: High Device and Procedure Cost
    • 6.1.4. Substitute: Hysterectomy
    • 6.1.5. Substitute: Intrauterine Devices
  • 6.2. Uterine Fibroid Embolization Agents
    • 6.2.1. Driver: Increasing Prevalence of Uterine Fibroids
    • 6.2.2. Driver: Improving Imaging Capabilities
    • 6.2.3. Barrier: Lack of Patient Awareness
    • 6.2.4. Substitute: MRI-guided Focused Ultrasound
    • 6.2.5. Substitute: Myomectomy
  • 6.3. Female Sterilization Devices
    • 6.3.1. Driver: Growing Female Population using Modern Contraception
    • 6.3.2. Driver: Increasing Adoption of Transcervical Sterilization
    • 6.3.3. Barrier: Patient Preference for Reversible Contraception
    • 6.3.4. Substitute: Traditional Contraception
  • 6.4. Female Urinary Incontinence Slings
    • 6.4.1. Driver: Growing Treatment Rates and Use of Surgery
    • 6.4.2. Barrier: Highly Litigious US Market
    • 6.4.3. Substitute: Surgical Repair
    • 6.4.4. Substitute: Pelvic Floor Electrical Stimulation

7. Competitive Assessment

  • 7.1. Overview
  • 7.2. Classification Based on Features
    • 7.2.1. Endometrial Ablation Devices
    • 7.2.2. Endometrial Resection Devices
    • 7.2.3. Uterine Fibroid Embolization Agents
    • 7.2.4. Female Sterilization Devices
    • 7.2.5. Female Urinary Incontinence Slings
  • 7.3. Key Product Profiles
    • 7.3.1. Endometrial Ablation Devices
    • 7.3.2. Endometrial Resection Devices
    • 7.3.3. Uterine Fibroid Embolization Agents
    • 7.3.4. Female Sterilization Devices
    • 7.3.5. Female Urinary Incontinence Slings

8. Pipeline Assessment

  • 8.1. Overview
  • 8.2. Key Product Profiles
    • 8.2.1. Endometrial Ablation Devices
    • 8.2.2. Uterine Fibroid Embolization Agents
    • 8.2.3. Female Sterilization Devices
    • 8.2.4. Female Urinary Incontinence Slings

9. Clinical Trials to Watch

  • 9.1. Overview
  • 9.2. Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation
  • 9.3. Post Market Study of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx)
  • 9.4. Safety & Effectiveness Study of Aegea Vapor System to Treat Excessive Uterine Bleeding
  • 9.5. The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence (EASY)

10. Current and Future Players

  • 10.1. Overview
  • 10.2. Trends in Corporate Strategy
  • 10.3. Company Profiles
    • 10.3.1. American Medical Systems
    • 10.3.2. AngioDynamics
    • 10.3.3. Bayer Healthcare (Bayer AG)
    • 10.3.4. Boston Scientific
    • 10.3.5. BTG
    • 10.3.6. Coloplast
    • 10.3.7. Cook Medical
    • 10.3.8. CooperSurgical
    • 10.3.9. C.R. Bard
    • 10.3.10. Ethicon (Johnson & Johnson)
    • 10.3.11. Femcare-Nikomed (Utah Medical Products)
    • 10.3.12. Hologic
    • 10.3.13. Karl Storz
    • 10.3.14. Olympus
    • 10.3.15. Richard Wolf
    • 10.3.16. Stryker

11. Market Outlook

  • 11.1. Company Market Share
    • 11.1.1. Global Overview
    • 11.1.2. By Segment
  • 11.2. By Market Segment
    • 11.2.1. Global Overview
    • 11.2.2. By Segment
  • 11.3. By Geography
    • 11.3.1. Global Overview
    • 11.3.2. By Region
    • 11.3.3. By Country

12. Appendix

  • 12.1. Bibliography
  • 12.2. Abbreviations
  • 12.3. Report Methodology
    • 12.3.1. Overview
    • 12.3.2. Coverage
    • 12.3.3. Secondary Research
  • 12.4. Forecasting Methodology
  • 12.5. Physicians and Specialists Included in This Study
  • 12.6. Primary Research - Prescriber Survey
  • 12.7. About the Authors
    • 12.7.1. Analysts
    • 12.7.2. Global Head of Medical Devices
  • 12.8. About GlobalData
  • 12.9. Disclaimer

List of Tables

  • Table 1: Types of Uterine Fibroids
  • Table 2: Types of Female Urinary Incontinence
  • Table 3: Drug and Hormone Treatments for Menorrhagia
  • Table 4: Surgical Treatments for Menorrhagia
  • Table 5: Treatments for Stress, Urge, and Mixed Urinary Incontinence
  • Table 6: Market Segmentation for Women's Health Market
  • Table 7: FDA Medical Device Classification System
  • Table 8: Regulatory Differences Between the US and EU for the Approval of Medical Devices
  • Table 9: CPT Codes and Description of Coverage for Gynecological Procedures
  • Table 10: APC Codes and Description of Coverage for Gynecological Procedures
  • Table 11: ICD-10 Codes Associated with Causes of Menorrhagia and Uterine Fibroids
  • Table 12: CPT Codes and Description of Coverage for Urinary Incontinence Sling Procedures
  • Table 13: APC Codes and Description of Coverage for Urinary Incontinence Sling Procedures
  • Table 14: ICD-10 Codes Associated with Female Stress Urinary Incontinence
  • Table 15: Endometrial Ablation Devices, SWOT Analysis, 2015
  • Table 16: Currently Marketed Endometrial Ablation Devices, 2015
  • Table 17: Endometrial Resection, SWOT Analysis, 2015
  • Table 18: Uterine Fibroid Embolization, SWOT Analysis, 2015
  • Table 19: Device-based Permanent Female Sterilization, SWOT Analysis, 2015
  • Table 20: Currently Marketed Notable Female Urinary Incontinence Slings, 2015
  • Table 21: Female Urinary Incontinence Slings, SWOT Analysis, 2015
  • Table 22: Product Profile - Cavaterm (Veldana Medical)
  • Table 23: Cavaterm, SWOT Analysis, 2015
  • Table 24: Product Profile - ThermaChoice (Ethicon)
  • Table 25: ThermaChoice, SWOT Analysis, 2015
  • Table 26: Product Profile - Genesys HTA (Boston Scientific)
  • Table 27: Genesys HTA, SWOT Analysis, 2015
  • Table 28: Product Profile - NovaSure (Hologic)
  • Table 29: NovaSure, SWOT Analysis, 2015
  • Table 30: Product Profile - Minerva Endometrial Ablation System (Minerva Surgical)
  • Table 31: Minerva Endometrial Ablation System, SWOT Analysis, 2015
  • Table 32: Product Profile - Her Option (CooperSurgical)
  • Table 33: Her Option, SWOT Analysis, 2015
  • Table 34: Product Profile - Acculis MTA (AngioDynamics)
  • Table 35: Acculis MTA, SWOT Analysis, 2015
  • Table 36: Product Profile - Acessa (Halt Medical)
  • Table 37: Acessa, SWOT Analysis, 2015
  • Table 38: Product Profile - Sonata (Gynesonics)
  • Table 39: Sonata, SWOT Analysis, 2015
  • Table 40: Product Profile - 26Fr Continuous Flow Resectoscope (Stryker)
  • Table 41: 26Fr Continuous Flow Resectoscope, SWOT Analysis, 2015
  • Table 42: Product Profile - Karl Storz Bipolar Resectoscope (Karl Storz)
  • Table 43: Karl Storz Bipolar Resectoscope, SWOT Analysis, 2015
  • Table 44: Product Profile - SurgMaster Resectoscope (Olympus)
  • Table 45: SurgMaster Resectoscope, SWOT Analysis, 2015
  • Table 46: Product Profile - Princess Resectoscope (Richard Wolf)
  • Table 47: Princess Resectoscope, SWOT Analysis, 2015
  • Table 48: Product Profile - Versapoint (Ethicon)
  • Table 49: Versapoint, SWOT Analysis, 2015
  • Table 50: Product Profile - Gelfoam (Pfizer)
  • Table 51: Gelfoam, SWOT Analysis, 2015
  • Table 52: Product Profile - Bead Block (BTG)
  • Table 53: Bead Block, SWOT Analysis, 2015
  • Table 54: Product Profile - Contour PVA Embolization Particles (Boston Scientific)
  • Table 55: Contour PVA Embolization Particles, SWOT Analysis, 2015
  • Table 56: Product Profile - PVA Foam Embolization Particles (Cook Medical)
  • Table 57: PVA Foam Embolization Particles, SWOT Analysis, 2015
  • Table 58: Product Profile - Embosphere Microspheres (Merit Medical Systems)
  • Table 59: Embosphere Microspheres, SWOT Analysis, 2015
  • Table 60: Product Profile - Filshie Clip (Femcare-Nikomed)
  • Table 61: Filshie Clip, SWOT Analysis, 2015
  • Table 62: Product Profile - Essure (Bayer Healthcare)
  • Table 63: Essure, SWOT Analysis, 2015
  • Table 64: Product Profile - Align Urethral Support System (C.R. Bard)
  • Table 65: Align Urethral Support System, SWOT Analysis, 2015
  • Table 66: Product Profile - Altis Single Incision Sling (Coloplast)
  • Table 67: Altis Single Incision Sling, SWOT Analysis, 2015
  • Table 68: Product Profile - Gynecare TVT (Ethicon)
  • Table 69: Gynecare TVT, SWOT Analysis, 2015
  • Table 70: Product Profile - MiniArc Single-Incision Sling (American Medical Systems)
  • Table 71: MiniArc Single-Incision Sling, SWOT Analysis, 2015
  • Table 72: Product Profile - Solyx (Boston Scientific)
  • Table 73: Solyx, SWOT Analysis, 2015
  • Table 74: Product Profile - Aegea Vapor System (Aegea Medical)
  • Table 75: Aegea Vapor System, SWOT Analysis, 2015
  • Table 76: Product Profile - Cryothermic Therapy (Channel Medsystems)
  • Table 77: Cryothermic Therapy, SWOT Analysis, 2015
  • Table 78: Product Profile - Biodegradable Bead
  • Table 79: Biodegradable Bead, SWOT Analysis, 2015
  • Table 80: Product Profile - FemBloc
  • Table 81: FemBloc, SWOT Analysis, 2015
  • Table 82: Product Profile - PTMC Mesh
  • Table 83: PTMC Mesh, SWOT Analysis, 2015
  • Table 84: Product Profile - sensiTVT
  • Table 85: sensiTVT, SWOT Analysis, 2015
  • Table 86: Company Profile - American Medical Systems
  • Table 87: American Medical Systems, SWOT Analysis, 2015
  • Table 88: Company Profile - AngioDynamics
  • Table 89: AngioDynamics, SWOT Analysis, 2015
  • Table 90: Company Profile - Bayer Healthcare
  • Table 91: Bayer Healthcare, SWOT Analysis, 2015
  • Table 92: Company Profile - Boston Scientific
  • Table 93: Boston Scientific, SWOT Analysis, 2015
  • Table 94: Company Profile - BTG
  • Table 95: BTG, SWOT Analysis, 2015
  • Table 96: Company Profile - Coloplast
  • Table 97: Coloplast, SWOT Analysis, 2015
  • Table 98: Company Profile - Cook Medical
  • Table 99: Cook Medical, SWOT Analysis, 2015
  • Table 100: Company Profile - CooperSurgical
  • Table 101: CooperSurgical, SWOT Analysis, 2015
  • Table 102: Company Profile - C.R. Bard
  • Table 103: C.R. Bard, SWOT Analysis, 2015
  • Table 104: Company Profile - Ethicon
  • Table 105: Ethicon, SWOT Analysis, 2015
  • Table 106: Company Profile - Femcare-Nikomed
  • Table 107: Femcare-Nikomed, SWOT Analysis, 2015
  • Table 108: Company Profile - Hologic
  • Table 109: Hologic, SWOT Analysis, 2015
  • Table 110: Company Profile - Karl Storz
  • Table 111: Karl Storz, SWOT Analysis, 2015
  • Table 112: Company Profile - Olympus
  • Table 113: Olympus, SWOT Analysis, 2015
  • Table 114: Company Profile - Richard Wolf
  • Table 115: Richard Wolf, SWOT Analysis, 2015
  • Table 116: Company Profile - Stryker
  • Table 117: Stryker, SWOT Analysis, 2015
  • Table 118: Global Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Table 119: Global Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Table 120: Global Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 121: Global Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Table 122: Global Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 123: Global Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Table 124: Global Women's Health Market Forecast ($m) by Country, 2011-2021
  • Table 125: 5EU Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Table 126: APAC Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Table 127: US Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Table 128: US Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Table 129: US Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 130: US Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Table 131: US Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 132: US Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Table 133: France Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Table 134: France Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Table 135: France Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 136: France Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Table 137: France Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 138: France Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Table 139: Germany Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Table 140: Germany Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Table 141: Germany Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 142: Germany Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Table 143: Germany Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 144: Germany Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Table 145: Italy Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Table 146: Italy Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Table 147: Italy Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 148: Italy Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Table 149: Italy Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 150: Italy Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Table 151: Spain Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Table 152: Spain Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Table 153: Spain Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 154: Spain Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Table 155: Spain Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 156: Spain Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Table 157: UK Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Table 158: UK Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Table 159: UK Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 160: UK Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Table 161: UK Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 162: UK Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Table 163: Japan Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Table 164: Japan Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Table 165: Japan Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 166: Japan Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Table 167: Japan Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 168: Japan Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Table 169: China Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Table 170: China Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Table 171: China Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 172: China Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Table 173: China Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 174: China Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Table 175: India Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Table 176: India Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Table 177: India Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 178: India Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Table 179: India Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 180: India Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Table 181: Brazil Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Table 182: Brazil Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Table 183: Brazil Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 184: Brazil Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Table 185: Brazil Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Table 186: Brazil Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021

List of Figures

  • Figure 1: Percentage Breakdown of Urinary Incontinence, by Type
  • Figure 2: Percentage of Patients with Menorrhagia Receiving Treatment, by Type
  • Figure 3: Percentage of Patients with Urinary Incontinence Receiving Treatment, by Type
  • Figure 4: US Procedure Volume Forecast, Endometrial Resection, 2011-2021
  • Figure 5: US Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021
  • Figure 6: US Procedure Volume Forecast, Female Sterilization, 2011-2021
  • Figure 7: US Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021
  • Figure 8: 5EU Procedure Volume Forecast, Endometrial Resection, 2011-2021
  • Figure 9: 5EU Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021
  • Figure 10: 5EU Procedure Volume Forecast, Female Sterilization, 2011-2021
  • Figure 11: 5EU Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021
  • Figure 12: APAC Procedure Volume Forecast, Endometrial Resection, 2011-2021
  • Figure 13: APAC Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021
  • Figure 14: APAC Procedure Volume Forecast, Female Sterilization, 2011-2021
  • Figure 15: APAC Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021
  • Figure 16: Brazil Procedure Volume Forecast, Endometrial Resection, 2011-2021
  • Figure 17: Brazil Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021
  • Figure 18: Brazil Procedure Volume Forecast, Female Sterilization, 2011-2021
  • Figure 19: Brazil Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021
  • Figure 20: Global Company Market Shares for Endometrial Ablation, 2014
  • Figure 21: Global Company Market Shares for Endometrial Resection, 2014
  • Figure 22: Global Company Market Shares for Uterine Fibroid Embolization Agents, 2014
  • Figure 23: Global Company Market Shares for Female Sterilization Devices 2014
  • Figure 24: Global Company Market Shares for Female Urinary Incontinence Slings, 2014
  • Figure 25: 5EU Company Market Shares for Female Urinary Incontinence Slings, 2014
  • Figure 26: APAC Company Market Shares for Female Urinary Incontinence Slings, 2014
  • Figure 27: Global Women's Health Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 28: Global Women's Health Market Share by Market Segment, 2014 and 2021
  • Figure 29: Global Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 30: Global Endometrial Ablation Market Share by Market Segment, 2014 and 2021
  • Figure 31: Global Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 32: Global TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 33: Global Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 34: Global Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
  • Figure 35: Global Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 36: Global Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
  • Figure 37: Global Female Urinary Incontinence Slings Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 38: Global Women's Health Market Forecast ($m) by Country, 2011-2021
  • Figure 39: Global Women's Health Market Share by Country, 2014 and 2021
  • Figure 40: 5EU Women's Health Market Forecast ($m) by Segment, 2011-2021
  • Figure 41: 5EU Women's Health Market Share by Market Segment, 2014 and 2021
  • Figure 42: APAC Women's Health Market Forecast ($m) by Segment, 2011-2021
  • Figure 43: APAC Women's Health Market Share by Market Segment, 2014 and 2021
  • Figure 44: US Women's Health Market Forecast ($m) by Segment, 2011-2021
  • Figure 45: US Women's Health Market Share by Market Segment, 2014 and 2021
  • Figure 46: US Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 47: US Endometrial Ablation Market Share by Market Segment, 2014 and 2021
  • Figure 48: US Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 49: US TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 50: US Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 51: US Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
  • Figure 52: US Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 53: US Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
  • Figure 54: US Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Figure 55: France Women's Health Market Forecast ($m) by Segment, 2011-2021
  • Figure 56: France Women's Health Market Share by Market Segment, 2014 and 2021
  • Figure 57: France Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 58: France Endometrial Ablation Market Share by Market Segment, 2014 and 2021
  • Figure 59: France Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 60: France TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 61: France Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 62: France Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
  • Figure 63: France Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 64: France Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
  • Figure 65: France Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Figure 66: Germany Women's Health Market Forecast ($m) by Segment, 2011-2021
  • Figure 67: Germany Women's Health Market Share by Market Segment, 2014 and 2021
  • Figure 68: Germany Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 69: Germany Endometrial Ablation Market Share by Market Segment, 2014 and 2021
  • Figure 70: Germany Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 71: Germany TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 72: Germany Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 73: Germany Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
  • Figure 74: Germany Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 75: Germany Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
  • Figure 76: Germany Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Figure 77: Italy Women's Health Market Forecast ($m) by Segment, 2011-2021
  • Figure 78: Italy Women's Health Market Share by Market Segment, 2014 and 2021
  • Figure 79: Italy Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 80: Italy Endometrial Ablation Market Share by Market Segment, 2014 and 2021
  • Figure 81: Italy Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 82: Italy TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 83: Italy Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 84: Italy Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
  • Figure 85: Italy Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 86: Italy Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Figure 87: Spain Women's Health Market Forecast ($m) by Segment, 2011-2021
  • Figure 88: Spain Women's Health Market Share by Market Segment, 2014 and 2021
  • Figure 89: Spain Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 90: Spain Endometrial Ablation Market Share by Market Segment, 2014 and 2021
  • Figure 91: Spain Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 92: Spain TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 93: Spain Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 94: Spain Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
  • Figure 95: Spain Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 96: Spain Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
  • Figure 97: Spain Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Figure 98: UK Women's Health Market Forecast ($m) by Segment, 2011-2021
  • Figure 99: UK Women's Health Market Share by Market Segment, 2014 and 2021
  • Figure 100: UK Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 101: UK Endometrial Ablation Market Share by Market Segment, 2014 and 2021
  • Figure 102: UK Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 103: UK TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 104: UK Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 105: UK Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
  • Figure 106: UK Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 107: UK Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
  • Figure 108: UK Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Figure 109: Japan Women's Health Market Forecast ($m) by Segment, 2011-2021
  • Figure 110: Japan Women's Health Market Share by Market Segment, 2014 and 2021
  • Figure 111: Japan Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 112: Japan Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 113: Japan TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 114: Japan Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 115: Japan Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
  • Figure 116: Japan Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 117: Japan Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
  • Figure 118: Japan Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Figure 119: China Women's Health Market Forecast ($m) by Segment, 2011-2021
  • Figure 120: China Women's Health Market Share by Market Segment, 2014 and 2021
  • Figure 121: China Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 122: China Endometrial Ablation Market Share by Market Segment, 2014 and 2021
  • Figure 123: China Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 124: China TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 125: China Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 126: China Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
  • Figure 127: China Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 128: China Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
  • Figure 129: China Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Figure 130: India Women's Health Market Forecast ($m) by Segment, 2011-2021
  • Figure 131: India Women's Health Market Share by Market Segment, 2014 and 2021
  • Figure 132: India Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 133: India Endometrial Ablation Market Share by Market Segment, 2014 and 2021
  • Figure 134: India Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 135: India TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 136: India Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 137: India Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
  • Figure 138: India Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 139: India Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
  • Figure 140: India Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Figure 141: Brazil Women's Health Market Forecast ($m) by Segment, 2011-2021
  • Figure 142: Brazil Women's Health Market Share by Market Segment, 2014 and 2021
  • Figure 143: Brazil Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 144: Brazil Endometrial Ablation Market Share by Market Segment, 2014 and 2021
  • Figure 145: Brazil Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 146: Brazil TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 147: Brazil Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 148: Brazil Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021
  • Figure 149: Brazil Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021
  • Figure 150: Brazil Female Sterilization Devices Market Share by Market Segment, 2014 and 2021
  • Figure 151: Brazil Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021
  • Figure 152: Primary Research Participants, by Country
Back to Top